Skip to main content
SpringerLink
Log in

Secondary Hypertension

  • Book
  • © 2020

Overview

Editors:
  1. Alberto Morganti

    1. Center of Clinical Physiology and Hypertension, Policlinic Hospital, University of Milan, Milan, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Enrico Agabiti Rosei

    1. Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  3. Franco Mantero

    1. Department of Medicine, Endocrine Unit, University of Padua, Padova, Italy

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  • Offers an updated overview of secondary hypertension causes and treatment
  • Describes relevant procedures in the treatment of secondary hypertension
  • Represents a useful guide for professionals to diagnose and treat this disease

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (14 chapters)

  1. Front Matter

    Pages i-x
    Download chapter PDF

  2. Renal Parenchymal Disease

    • Michel Burnier, Francesca Viazzi, Giovanna Leoncini, Grégoire Wuerzner, Roberto Pontremoli
    Pages 1-19

  3. Atherosclerotic Renovascular Disease

    • Peter W. de Leeuw, Costas Tsioufis
    Pages 21-32

  4. Fibromuscular Dysplasia: From a Rare Cause of Renovascular Hypertension to a More Frequent Systemic Arterial Disease

    • Marco Pappaccogli, Alexandre Persu, Alberto Morganti
    Pages 33-57

  5. Primary Aldosteronism

    • Gian Paolo Rossi
    Pages 59-78

  6. Familial Hyperaldosteronism

    • Alessio Pecori, Silvia Monticone, Isabel Losano, Giovanni Cavaglià, Jacopo Pieroni, Franco Veglio et al.
    Pages 79-93

  7. Monogenic Forms of Hypertension

    • Filippo Ceccato, Franco Mantero
    Pages 95-107

  8. Pheochromocytoma and Paraganglioma

    • Andrzej Januszewicz, Aleksander Prejbisz, Piotr Dobrowolski, Magdalena Januszewicz
    Pages 109-125

  9. Hypertension in Cushing’s Syndrome

    • Filippo Ceccato, Mattia Barbot, Carla Scaroni, Marco Boscaro
    Pages 127-139

  10. Vascular Disease

    • Stéphane Laurent
    Pages 141-148

  11. Obstructive Sleep Apnea

    • Joanna Kanarek-Kucner, Jacek Wolf, Krzysztof Narkiewicz
    Pages 149-158

  12. Drug-Induced Hypertension

    • Aurélien Lorthioir, Ines Belmihoub, Laurence Amar, Michel Azizi
    Pages 159-166

  13. Hypertension in Acromegaly

    • Peter Kamenický, Philippe Chanson
    Pages 167-179

  14. Organ Damage

    • Enrico Agabiti Rosei, Damiano Rizzoni, Claudia Agabiti-Rosei, Anna Paini, Maria Lorenza Muiesan
    Pages 181-195

  15. Secondary Hypertension and Cardiovascular Risk: An Overview

    • Gino Seravalle, Giuseppe Mancia, Guido Grassi
    Pages 197-209
Back to top

Keywords

About this book

This book offers an overview of the latest advances in the epidemiological, pathophysiological, diagnostic and therapeutic aspects of secondary hypertension, provided by a group of the most highly respected European experts in this field. It is common belief that secondary forms of hypertension are rare, although in 95% of patients the cause of high blood pressure is unknown – euphemistically referred to as “essential”. There is increasing evidence from epidemiological studies that the prevalence of secondary hypertension is much higher than previously thought, accounting for 20%-25% of all hypertensive patients. There are additional, very good reasons for identifying those patients with secondary hypertension: firstly, they are exposed to a greater risk of suffering major cardiovascular events than patients with essential hypertension who have the same blood pressure level, and for this reason require particular care. Secondly, these patients can be relieved of a lifetime of pharmacological therapy or, at least, have a chance to be treated with more specific and effective medications. A high degree of clinical skill is required to recognize the often vague and subtle symptoms and signs that characterize patients with secondary hypertension, and clinicians need to fully comprehend the mechanisms responsible for the development and maintenance of high blood pressure. Shedding new light on a complex area of cardiovascular medicine, the book enables readers to better treat affected patients.

Editors and Affiliations

  • Center of Clinical Physiology and Hypertension, Policlinic Hospital, University of Milan, Milan, Italy

    Alberto Morganti

  • Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy

    Enrico Agabiti Rosei

  • Department of Medicine, Endocrine Unit, University of Padua, Padova, Italy

    Franco Mantero

About the editors

Alberto Morganti joined Professor Alberto Zanchetti’s group at the Policlinico Hospital in Milan after his degree, and was was introduced to the pathophysiological and clinical aspects of hypertension. He then spent two years working as a research associate and clinical fellow at the Cardiovascular Hypertension Center-Cornell University Medical College in New York Hospital under the guidance of professor John Laragh, and upon his return to Milan he became responsible of the radioimmunoassay laboratory in his original institution, where he conducted several multicenter international studies on the methodological aspects of renin measurements. He has since expanded his research interests to include secondary forms of hypertension and, in particular, to the diagnosis and treatment of renovascular hypertension. Professor Morganti was director of the Hypertension Center at the San Paolo Hospital and San Giuseppe Hospital. Moreover he served as treasurer of the International Society of Hypertension from 2000 to 2008 and as president of the Italian Society of Hypertension from 2009 to 2011.  
Enrico Agabiti-Rosei has been a professor of internal medicine at the University of Brescia (Italy) since 1990. He is director of the Clinica Medica at the University of Brescia and chairman of the Department of Internal Medicine, Azienda Spedali Civili, University Hospital of Brescia, Italy. He graduated in medicine and surgery at the University of Perugia and specialized in cardiology and internal medicine at the University of Pisa. He has lectured internationally on topics related to hypertension and cardiovascular diseases and has been responsible for organizing official workshops and symposia for the European Society of Hypertension, and of the European Society of Cardiology. He was president of the European Society of Hypertension and the Italian Society of Hypertension, and chairman of the European Society of Cardiology’s working group Hypertension and the Heart. He was also a member of the European Society of Cardiology Science Council and the European Council for Cardiovascular Research’s Executive Committee. He received the ESH Peter Sleight Award in 2011. 
Franco Mantero graduated cum laude in Medicine at the University of Padua Medical School. He then specialised in Endocrinology at University of Florence, in Radiology, Nephrology and Internal Medicine at the University of Padua. He has been scientific secretary of several International Meetings on Adrenal and Pituitary and Endocrine Hypertension, editor of several books about special Issue on adrenals and hypertension. Memeber of many scientifical internation societies, he is also in the editorial board of many international journals and published more than 500 papers.


Franco Mantero graduated at the University of Padua and specialized in Endocrinology, Nephrology, Internal Medicine and Nuclear Medicine. He trained at the UH ofGeneva (Switzerland) and at the CRC  of the UCSF(USA). After his return to Padua he established a national referral center for adrenal diseases. His primary research interests are mineralocorticoid hypertension, Cushing’s Syndrome, adrenal tumors. He has been professor of Endocrinology and chair of the Division of Endocrinology of the Padua University Hospital. He organized International Meetings on Adrenal  and Endocrine Hypertension, and lectured in Meetings of the European Society of Endocrinology, Endocrine Society(USA), International Society of Endocrinology, and European Society of Hypertension. He is editor of several books on adrenals and hypertension. Member of the steering committee of many scientific societies (including International Society of Endocrinology, International Aldosterone Conference) and co-founder of the European Study Group on Adrenal Tumors (ENSAT). He is also in the editorial board of many international journals and published more than 500 papers.



Bibliographic Information

  • Book Title: Secondary Hypertension

  • Editors: Alberto Morganti, Enrico Agabiti Rosei, Franco Mantero

  • Series Title: Updates in Hypertension and Cardiovascular Protection

  • DOI: https://doi.org/10.1007/978-3-030-45562-0

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer Nature Switzerland AG 2020

  • Hardcover ISBN: 978-3-030-45561-3Published: 08 July 2020

  • Softcover ISBN: 978-3-030-45564-4Published: 08 July 2021

  • eBook ISBN: 978-3-030-45562-0Published: 07 July 2020

  • Series ISSN: 2366-4606

  • Series E-ISSN: 2366-4614

  • Edition Number: 1

  • Number of Pages: X, 209

  • Number of Illustrations: 13 b/w illustrations, 9 illustrations in colour

  • Topics: Cardiology, Nephrology, Endocrinology, Neurology

Publish with us

Policies and ethics

Back to top

Search

Navigation